Edgewise Therapeutics Inc. | Small-cap | Healthcare
$12.61
-3.22%
| Edgewise Stock Comparison:
Edgewise vs VertexEdgewise vs RegeneronEdgewise vs Vera TherapeuticsEdgewise vs Immunocore HoldingsEdgewise vs AgiosEdgewise vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 0
Operating Income -158.8M
Net Income -133.8M

Balance Sheet Metrics

Total Assets 486.8M
Total Liabilities 27.6M
Shareholders Equity 459.2M
Debt to Equity 0.06

Cash Flow Metrics

Operating Cash Flow -105.3M
Free Cash Flow -110.3M

Revenue & Profitability Trend

Edgewise Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue00000
Cost of Goods Sold-----
Gross Profit-----
Operating Expenses158.8M114.4M71.7M43.2M17.2M
Operating Income-158.8M-114.4M-71.7M-43.2M-17.2M
Pre-tax Income-133.8M-100.2M-67.6M-42.8M-17.1M
Income Tax-----
Net Income-133.8M-100.2M-67.6M-42.8M-17.1M
EPS (Diluted)--$1.57-$1.26-$1.14-$0.37

Income Statement Trend

Edgewise Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets475.5M327.0M357.0M283.8M129.6M
Non-Current Assets11.3M13.0M10.1M1.5M1.5M
Total Assets486.8M340.0M367.1M285.2M131.1M
Liabilities
Current Liabilities23.9M16.8M16.6M10.5M4.3M
Non-Current Liabilities3.7M4.4M3.8M329.0K160.2M
Total Liabilities27.6M21.2M20.4M10.8M164.6M
Equity
Total Shareholders Equity459.2M318.8M346.7M274.4M-33.4M

Balance Sheet Composition

Edgewise Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-133.8M-100.2M-67.6M-42.8M-17.1M
Operating Cash Flow-105.3M-81.1M-52.0M-33.9M-15.2M
Investing Activities
Capital Expenditures-1.3M-5.7M-5.5M-668.0K-203.0K
Investing Cash Flow-184.7M102.9M-70.6M-242.2M-24.4M
Financing Activities
Dividends Paid-----
Financing Cash Flow238.9M52.5M128.9M186.0M120.1M
Free Cash Flow-110.3M-97.7M-58.2M-34.2M-14.8M

Cash Flow Trend

Edgewise Key Financial Ratios

Valuation Ratios

Forward P/E -7.73
Price to Book 3.17
PEG Ratio -7.73

Profitability Ratios

Profit Margin 0.00%
Operating Margin 0.00%
Return on Equity -30.29%
Return on Assets -21.08%

Financial Health

Current Ratio 20.99
Debt to Equity 1.06
Beta 0.29

Per Share Data

EPS (TTM) -$1.55
Book Value per Share $4.51

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
ewtx1.5B-3.17-30.29%0.00%1.06
Vertex 114.1B32.826.92-5.64%-8.91%10.00
Regeneron 55.3B13.021.8415.96%31.94%9.20
Vera Therapeutics 1.4B-8.412.58-39.49%0.00%10.18
Immunocore Holdings 1.6B-31.414.13-5.86%-6.48%114.67
Agios 1.9B2.891.3260.26%1,798.26%3.61

Financial data is updated regularly. All figures are in the company's reporting currency.